SARS-CoV-2 Infection in Asymptomatic Patients Hospitalized for Cardiac Emergencies: Implications for Patient ManagementCardiovascular Medicine Published on 2020-12-182022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] Admission Admissions analyzed Asymptomatic body temperature cardiac cardiac emergencies cardiovascular risk Care changed coronavirus disease COVID-19 COVID-19 crisis COVID-19 symptom COVID-19 symptoms determine equipment Health hospital hospitalized patient infected patients Mortality Nasopharyngeal swab Non-COVID-19 pandemic Patient patients Personal protective equipment (PPE) positive presenting Prevalence Protective questionnaire Region resource SARS-CoV-2 SARS-COV-2 infection screened Screening Swab test tested Treatment [DOI] 10.3389/fcvm.2020.599299 PMC 바로가기 [Article Type] Cardiovascular Medicine
Antecedent Administration of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Antagonists and Survival After Hospitalization for COVID-19 SyndromeObservational Study Published on 2020-11-172022-10-05 Journal: Journal of the American Heart Association [Category] 임상, [키워드] 95% CI ACE-2 ACEi acute respiratory syndrome administration affected age Analysis Angiotensin II angiotensin-converting enzyme inhibitor angiotensin-converting enzyme-2 angiotensin‐converting enzyme inhibitor angiotensin‐converting enzyme‐2 antagonist antecedent ARB cardiovascular risk congestive heart failure Coracle coronavirus coronavirus disease COVID-19 COVID‐19 death Diabetes Mellitus enzyme groups Hospitalization Hospitalized human cells hypertension in-hospital mortality inhibitor Italy Mortality Odds ratio Older overall mortality Patient patients patients hospitalized Primary outcome protective role receptor reduced reduced risk Region renin‐angiotensin converting enzyme inhibitor. Result SARS-CoV-2 SARS‐CoV‐2 Sex smoking status trend upregulation while with COVID-19 [DOI] 10.1161/JAHA.120.017364 PMC 바로가기 [Article Type] Observational Study
Hypertension and SARS-CoV-2 infection: is inflammation the missing link?Review Published on 2020-11-012023-07-12 Journal: Cardiovascular Research [Category] SARS, [키워드] cardiovascular risk Cytokine storm hypertension Inflammation SARS-CoV2 infection Toll-like 4 receptor. [DOI] 10.1093/cvr/cvaa273 PMC 바로가기 [Article Type] Review
Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidatesReview Published on 2020-11-012023-07-12 Journal: Rheumatology International [Category] SARS, [키워드] cardiovascular risk Colchicine fibrosis Hydroxychloroquine methotrexate thrombosis [DOI] 10.1007/s00296-020-04694-2 PMC 바로가기 [Article Type] Review
Cardiovascular health care and health literacy among immigrants in Europe: a review of challenges and opportunities during the COVID-19 pandemicReview Article Published on 2020-10-272022-10-28 Journal: Zeitschrift Fur Gesundheitswissenschaften [Category] COVID-19, [키워드] cardiovascular cardiovascular disease cardiovascular risk Care challenge chronic disease coronavirus disease COVID-19 COVID-19 pandemic COVID-2019 CVD diabetes distribution element Europe Evidence Health Health care system health literacy Health status healthy help Host hypertension Implementing IMPROVE in some Inclusion Intervention migrants Mortality objective outcome outcomes pandemic performed proportion public health Public health response Result risk Risk factors SARS-CoV-2 Specific subgroup subset targeted interventions the healthy [DOI] 10.1007/s10389-020-01405-w PMC 바로가기 [Article Type] Review Article
Recommendations for Cardiovascular Prevention During the Sars-Cov-2 Pandemic: An Executive Document by the Board of the Italian Society of Cardiovascular PreventionPractice Guideline Published on 2020-10-012023-07-06 Journal: High blood pressure & cardiovascular prevention : [Category] SARS, [키워드] cardiovascular prevention cardiovascular risk COVID-19 SARS-CoV-2 [DOI] 10.1007/s40292-020-00401-1 PMC 바로가기 [Article Type] Practice Guideline
Revisiting the cardiovascular risk of hydroxychloroquine in RA News & Views Published on 2020-09-302022-10-05 Journal: Nature reviews. Rheumatology [Category] SARS, 치료제, [키워드] cardiovascular risk Hydroxychloroquine [DOI] 10.1038/s41584-020-00521-x [Article Type] News & Views
Cardiovascular Involvement in Kawasaki Disease Is Much More Than Mere Coronary ArteritisPediatrics Published on 2020-09-242022-10-31 Journal: Frontiers in Pediatrics [Category] COVID-19, [키워드] Abnormalities abnormality acquired heart disease Cardiac biomarkers cardiovascular cardiovascular risk children clinically Complication Coronary Coronary artery dysfunction echocardiography Follow-up increasingly Involvement Kawasaki disease Kawasaki disease shock syndrome myocarditis Patient Pericarditis reported serious complication Shock syndrome valvular [DOI] 10.3389/fped.2020.526969 PMC 바로가기 [Article Type] Pediatrics
COVID-19 and ethnicity: A novel pathophysiological role for inflammationResearch article Published on 2020-09-012022-10-05 Journal: Diabetes & metabolic syndrome [Category] SARS, 유전자 메커니즘, [키워드] Acute inflammation appear article articles Bame black can be used cardiovascular disease cardiovascular risk chronic disease chronic infection chronic inflammation chronic systemic inflammation contributing to COVID-19 COVID-19 mortality COVID-19 research Cytokine storm database disease severity dysregulation elevated English Ethnicity explain Factor Genetic predisposition Google Scholar identify Inflammation insulin resistance management metabolic syndrome National obesity pathophysiological pathophysiological mechanism performed phenotype pro-inflammatory cytokine provide Psychological Psychological stress Research Result risk SARS CoV-2 searched severe COVID-19 disease severe disease significantly Stress Type 2 diabetes mellitus visceral fat [DOI] 10.1016/j.dsx.2020.06.056 [Article Type] Research article
Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysisResearch Article Published on 2020-08-142022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] 95% CI affected analysed Analysis association calculate cardiovascular cardiovascular comorbidity cardiovascular complication cardiovascular event cardiovascular risk cardiovascular risk factor cause Clinical outcome Cochran Q test Comorbidity Complication contribute COVID-19 COVID-19 patient COVID-19 patients death eligible event Extracted higher risk Hospitalization hospitalized COVID-19 patient hospitalized patient Impact Infection ISI MedCalc Meta-analysis meta-regression mild illness Mortality novel observational study Older age outcome pandemic Patient proportion random-effects model Registered Result secondary selected significant interaction significantly statistical subjects Symptom was used were recorded with COVID-19 [DOI] 10.1371/journal.pone.0237131 PMC 바로가기 [Article Type] Research Article